X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (10367) 10367
Book Review (1740) 1740
Publication (888) 888
Book / eBook (243) 243
Book Chapter (188) 188
Newsletter (181) 181
Newspaper Article (112) 112
Conference Proceeding (30) 30
Dissertation (18) 18
Transcript (14) 14
Trade Publication Article (8) 8
Web Resource (7) 7
Magazine Article (5) 5
Data Set (2) 2
Government Document (2) 2
Journal / eJournal (1) 1
Reference (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (8452) 8452
humans (7033) 7033
cytogenetics (6164) 6164
female (4003) 4003
male (3970) 3970
oncology (3060) 3060
middle aged (2896) 2896
adult (2840) 2840
hematology (2738) 2738
aged (2208) 2208
cancer (1922) 1922
analysis (1781) 1781
cytogenetic analysis (1773) 1773
prognosis (1669) 1669
genetics & heredity (1607) 1607
animals (1480) 1480
genetic aspects (1433) 1433
research (1399) 1399
chromosome aberrations (1356) 1356
chromosomes (1265) 1265
chronic myelogenous leukemia (1207) 1207
adolescent (1179) 1179
leukemia (1160) 1160
treatment outcome (1155) 1155
mutation (1059) 1059
in situ hybridization, fluorescence (1042) 1042
aged, 80 and over (999) 999
imatinib mesylate (913) 913
genes (890) 890
leukemia, myelogenous, chronic, bcr-abl positive - drug therapy (873) 873
genetics (871) 871
care and treatment (796) 796
gene expression (788) 788
chemotherapy (787) 787
cell biology (776) 776
young adult (771) 771
child (756) 756
survival (754) 754
antineoplastic agents - therapeutic use (749) 749
chronic myeloid leukemia (717) 717
pathology (701) 701
karyotyping (700) 700
chronic myeloid-leukemia (697) 697
therapy (678) 678
genomics (676) 676
genetic research (674) 674
benzamides (672) 672
expression (662) 662
in-situ hybridization (656) 656
diagnosis (652) 652
comparative genomic hybridization (650) 650
cytogenetic responses (638) 638
health aspects (635) 635
mice (629) 629
pyrimidines - therapeutic use (609) 609
tumors (609) 609
hematology, oncology and palliative medicine (590) 590
risk factors (586) 586
cells (584) 584
abridged index medicus (581) 581
leukemia, myeloid, acute - genetics (578) 578
dna (570) 570
retrospective studies (566) 566
medicine (564) 564
biology (559) 559
medicine & public health (553) 553
acute myeloid leukemia (550) 550
stem cells (549) 549
research article (547) 547
acute myeloid-leukemia (542) 542
mutations (540) 540
leukemia, myelogenous, chronic, bcr-abl positive - genetics (536) 536
piperazines - therapeutic use (536) 536
transplantation (517) 517
child, preschool (501) 501
imatinib (500) 500
gastroenterology & hepatology (499) 499
toxicology (498) 498
article (496) 496
bone marrow (493) 493
proteins (489) 489
life sciences (485) 485
patients (479) 479
antineoplastic combined chemotherapy protocols - therapeutic use (468) 468
translocation, genetic (468) 468
gene (466) 466
survival analysis (466) 466
remission induction (449) 449
physiological aspects (448) 448
hemic and lymphatic diseases (437) 437
genomes (429) 429
fluorescence (425) 425
follow-up studies (424) 424
hybridization (424) 424
fish (423) 423
multidisciplinary sciences (422) 422
survival rate (421) 421
disease-free survival (420) 420
acute lymphoblastic-leukemia (418) 418
gastroenterology and hepatology (412) 412
more...
Library Location Library Location
Library Location Library Location
X
Sort by Item Count (A-Z)
Filter by Count
Gerstein Science - Stacks (161) 161
UTL at Downsview - May be requested (35) 35
UofT at Mississauga - Stacks (34) 34
Earth Sciences (Noranda) - Stacks (12) 12
Online Resources - Online (10) 10
UofT at Scarborough - Stacks (10) 10
Collection Dvlpm't (Acquisitions) - Closed Orders (9) 9
Royal Ontario Museum - Stacks (8) 8
Collection Dvlpm't (Acquisitions) - Vendor file (4) 4
UofT at Scarborough - Withdrawn (4) 4
Trinity College (John W Graham) - Stacks (3) 3
Gerstein Science - Periodical Stacks (2) 2
Physics - Stacks (2) 2
UofT at Scarborough - May be requested in 6-10 wks (2) 2
Gerstein Science - Missing (1) 1
Gerstein Science - Theses (1) 1
Regis College - Stacks (1) 1
Robarts - Stacks (1) 1
Scarborough Hospital - General (1) 1
Sunnybrook Health Sciences Centre - Sunnybrook Stacks (1) 1
Thomas Fisher Rare Book - Rare Book (1) 1
University Archives - Archives (1) 1
UofT at Scarborough - May be requested (1) 1
Victoria University E.J. Pratt - Stacks (1) 1
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (10943) 10943
Russian (70) 70
French (40) 40
German (27) 27
Spanish (17) 17
Chinese (10) 10
Japanese (9) 9
Portuguese (8) 8
Korean (6) 6
Arabic (4) 4
Slovenian (4) 4
Bulgarian (2) 2
Hungarian (2) 2
Slovak (2) 2
Ukrainian (2) 2
Croatian (1) 1
Czech (1) 1
Danish (1) 1
Dutch (1) 1
Hebrew (1) 1
Lithuanian (1) 1
Persian (1) 1
Polish (1) 1
Serbian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Cancer, ISSN 0008-543X, 02/2008, Volume 112, Issue 4, pp. 837 - 845
Journal Article
Journal Article
Leukemia, ISSN 0887-6924, 09/2012, Volume 26, Issue 9, pp. 2096 - 2102
Journal Article
Journal Article
Journal Article
Journal Article
British Journal of Haematology, ISSN 0007-1048, 05/2019, Volume 185, Issue 3, pp. 450 - 467
Journal Article
Cancer, ISSN 0008-543X, 04/2005, Volume 103, Issue 8, pp. 1659 - 1669
BACKGROUND. The advent of imatinib has considerably changed the treatment of chronic myeloid leukemia (CML). Early studies demonstrated high rates of... 
Hematologic resistance | Imatinib | Chronic myeloid leukemia | Clinical strategies | CHRONIC MYELOGENOUS LEUKEMIA | CYTOGENETIC RESPONSES | CHRONIC-PHASE | PROGNOSTIC-FACTORS | imatinib | RESIDUAL DISEASE | hematologic resistance | CHRONIC MYELOID-LEUKEMIA | clinical strategies | INTERFERON-ALPHA | ONCOLOGY | chronic myeloid leukemia | TYROSINE KINASE INHIBITOR | MESYLATE THERAPY | CML PATIENTS | Humans | Middle Aged | Leukemia, Myelogenous, Chronic, BCR-ABL Positive - drug therapy | Salvage Therapy | Leukemia, Myelogenous, Chronic, BCR-ABL Positive - genetics | Neoplasm Recurrence, Local - drug therapy | Drug Resistance, Neoplasm | Male | Antineoplastic Agents - therapeutic use | Neoplasm Recurrence, Local - pathology | Precursor Cell Lymphoblastic Leukemia-Lymphoma - drug therapy | Leukemia, Myelogenous, Chronic, BCR-ABL Positive - pathology | Adult | Female | Cytogenetic Analysis | Precursor Cell Lymphoblastic Leukemia-Lymphoma - pathology | Blast Crisis | Survival Rate | Treatment Outcome | Piperazines - therapeutic use | Imatinib Mesylate | Remission Induction | Precursor Cell Lymphoblastic Leukemia-Lymphoma - genetics | Fusion Proteins, bcr-abl - genetics | Pyrimidines - therapeutic use | Adolescent | Neoplasm Recurrence, Local - genetics | Aged | Interferon-alpha - adverse effects | Benzamides | Mutation | Fusion Proteins, bcr-abl - metabolism | Protein-Tyrosine Kinases - antagonists & inhibitors | Care and treatment | Research | History | Leukemia | Index Medicus | Abridged Index Medicus
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 05/2010, Volume 28, Issue 14, pp. 2381 - 2388
Purpose There is a considerable variability in the level of molecular responses achieved with imatinib therapy in patients with chronic myeloid leukemia (CML).... 
OCT-1 ACTIVITY | THERAPY | CHRONIC-PHASE | ONCOLOGY | KINASE DOMAIN MUTATIONS | STANDARD-DOSE IMATINIB | SUBOPTIMAL RESPONSE | NONADHERENCE | DETERMINANT | CML PATIENTS | BCR-ABL TRANSCRIPTS | Humans | Middle Aged | Leukemia, Myelogenous, Chronic, BCR-ABL Positive - drug therapy | Leukemia, Myelogenous, Chronic, BCR-ABL Positive - genetics | Male | Antineoplastic Agents - therapeutic use | RNA, Messenger - metabolism | Young Adult | Time Factors | Aged, 80 and over | Adult | Drug Monitoring - instrumentation | Female | Antineoplastic Agents - pharmacokinetics | Micro-Electrical-Mechanical Systems - instrumentation | Cytogenetic Analysis | Piperazines - pharmacokinetics | Protein Kinase Inhibitors - pharmacokinetics | Risk Assessment | Risk Factors | Kaplan-Meier Estimate | Proportional Hazards Models | Logistic Models | Treatment Outcome | Octamer Transcription Factor-1 - genetics | Piperazines - therapeutic use | Gene Expression Regulation, Leukemic | Imatinib Mesylate | ATP Binding Cassette Transporter, Subfamily B | ATP Binding Cassette Transporter, Subfamily B, Member 1 - genetics | Polymorphism, Genetic | Fusion Proteins, bcr-abl - genetics | Medication Adherence | Protein Kinase Inhibitors - therapeutic use | Pyrimidines - therapeutic use | Pyrimidines - pharmacokinetics | Aged | Benzamides | Mutation | Index Medicus | Hema7 | ORIGINAL REPORTS | Hema5
Journal Article
Journal Article
Plant Cell, ISSN 1040-4651, 02/2017, Volume 29, Issue 2, pp. 331 - 344
Plants growing at high densities elongate their shoots to reach for light, a response known as the shade avoidance syndrome (SAS). Phytochrome-mediated... 
AVOIDANCE-RESPONSE | EXPRESSION ANALYSIS | BOTRYTIS-CINEREA | BIOCHEMISTRY & MOLECULAR BIOLOGY | NEIGHBOR DETECTION | PLANT SCIENCES | CELL BIOLOGY | SIGNAL-TRANSDUCTION | GROWTH-RESPONSES | AUXIN | NATURAL VARIATION | GENE-EXPRESSION | PHYTOCHROME | Plant Shoots - physiology | Plant Shoots - growth & development | Arabidopsis - physiology | Botrytis | Plant Shoots - microbiology | Geranium - radiation effects | Species Specificity | Arabidopsis - growth & development | Plant Proteins - physiology | Plant Diseases - immunology | Plant Shoots - radiation effects | Stress, Physiological | Transcriptome | Plant Diseases - microbiology | Gene Expression Profiling | Geranium - physiology | Arabidopsis - radiation effects | Plant Proteins - genetics | Geranium - growth & development | Sequence Analysis, RNA | Geranium - microbiology | Gene Expression Regulation, Plant | Plant Proteins - metabolism | Disease Resistance - genetics | RNA sequencing | Arabidopsis thaliana | Plant genetics | Phytochrome | Protein binding | Shade-tolerant plants | Physiological aspects | Genetic aspects | Plant cytogenetics | Analysis | Cues | Light quality | Enrichment | Regulators | Kinases | Ribonucleic acid--RNA | Physiological responses | Immunity | Light effects | Gene sequencing | Shade | Understory | Life cycle engineering | Indigenous species | Shoots | Light reflection | Species | Elongation | Avoidance | Deoxyribonucleic acid--DNA | Life cycles | Index Medicus
Journal Article